"Renovatio Clinical is at the heart of Houston clinical trials. We are a clinical research company with over 20 years of combined experience."

During the past decade, Renovatio Clinical conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 12 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 12 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Renovatio Clinical" #1 sponsor was "Incyte Corporation" with 12 trials, followed by "Hutchmed" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Renovatio Clinical" #1 collaborator was "Genmab" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Renovatio Clinical" are "Lymphoma" (4 trials), "Myelofibrosis" (3 trials), "Alpha1-Antitrypsin Deficiency" (2 trials), "Breast Cancer" (2 trials) and "Esophageal Cancer" (2 trials). Many other conditions were trialed in "Renovatio Clinical" in a lesser frequency.

Most popular intervention types in "Renovatio Clinical" are "Drug" (40 trials), "Other" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Parsaclisib" (4 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Renovatio Clinical" are 43 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Renovatio Clinical". undefined are not yet recruiting, 14 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Renovatio Clinical, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Renovatio Clinical, 6 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".